Jason M. Devgun

ORCID: 0000-0003-3435-319X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Poisoning and overdose treatments
  • Opioid Use Disorder Treatment
  • Pharmaceutical Practices and Patient Outcomes
  • Venomous Animal Envenomation and Studies
  • Anesthesia and Sedative Agents
  • Drug-Induced Hepatotoxicity and Protection
  • Supramolecular Self-Assembly in Materials
  • Animal Ecology and Behavior Studies
  • RNA Interference and Gene Delivery
  • Plant-based Medicinal Research
  • Diabetes Management and Research
  • Pharmacological Effects and Toxicity Studies
  • Pain Management and Opioid Use
  • Pharmacovigilance and Adverse Drug Reactions
  • COVID-19 Clinical Research Studies
  • Metabolism, Diabetes, and Cancer
  • Rabies epidemiology and control
  • Insect and Pesticide Research
  • Epilepsy research and treatment
  • Animal testing and alternatives
  • Forensic Toxicology and Drug Analysis
  • Polydiacetylene-based materials and applications
  • Diabetes Treatment and Management
  • Silk-based biomaterials and applications
  • Immunotoxicology and immune responses

Washington University in St. Louis
2020-2023

University of Colorado Denver
2020-2021

Molecular Biology Consortium
2019

Toxikon (United States)
2019

University of Chicago
2009-2011

Abbott (United States)
2011

The rapid spread and mortality associated with COVID-19 emphasized a need for surveillance system development to identify adverse events (AEs) emerging therapeutics. Bradycardia is remdesivir infusion-associated AE listed in the US Food Drug Administration-approved prescribing information.To evaluate magnitude duration of bradycardic following administration.A multicenter cohort study patients recorded heart rate less than 60 beats per minute within 24 hours after administration dose was...

10.1001/jamanetworkopen.2022.55815 article EN cc-by-nc-nd JAMA Network Open 2023-02-14

One of the advantages materials produced by self-assembly is that in principle they can be formed any given container to produce predetermined shapes and sizes. Here, we developed a method for triggering peptide within aqueous phase water-in-oil emulsions spherical microgels composed fibrillized peptides. Size control over was achieved specification blade type, speed, additional shear steps emulsion process. Microgels constructed this way could then embedded other self-assembled matrices...

10.1039/c1sm05504f article EN Soft Matter 2011-01-01
Jennifer S. Love Dana L. Karshenas Meghan B. Spyres Lynn A. Farrugia A. Min Kang and 95 more HoanVu Nguyen Sharan Campleman Shao Li Paul M. Wax Jeffery Brent Kim Aldy Michael G. Abesamis Jennifer Acciani Elizabeth Adeyeye Alek Adkins Peter Akpunonu Hassan Al Balushi Timothy E. Albertson Adam Algren Alexandra Amaducci John Archer Robert Avera Kavita M. Babu Keith Baker Kevin Baumgartner Noah Bearlin Gillian A. Beauchamp Vik Bebarta David J. Betting Michael C. Beuhler Steven Bird Matthew Blundell William Boroughf Kayla Bourgeois Katherine Boyle Evan Bradley Wells Brambl Nicklaus Brandehoff Marielle Brenner Daniel Brooks Jennie Buchanan Michele M. Burns Alfred Cahana Kevin Caja Diane P. Calello Vince Calleo Alexa Camarena-Michel Joshua Canning Robert D. Cannon Dazhe Cao Jennifer Carey Joseph Carpenter Stephanie Carreiro Jorge Andrés Ramos Castañeda Rachel Castelli Vincent Ceretto Edward W. Cetaruk James Chenoweth Michael Christian Richard Church Joseph Clemons Daniel Colby Grant Thomas Comstock Albert Conicella Matthew D. Cook Matt Correia Robert A. Cox Arthur Daigh Paul I. Dargan Klara De Baerdemaeker Anthony DeGelorm Jonathan de Olano Jason M. Devgun Christopher Dion William H. Dribben Anna Dean Dulaney Bernard Eisenga Lindsey Epperson Rita Farah Hank Farrar Sing-Yi Feng Derek J Fikse E.M.R. Fisher Jonathan Ford Carolyn Fox K.A. French Blake Froberg Jakub Furmaga Michael Ganetsky Ann-Jeannette Geib Mellisa Gittinger Kimberlie A. Graeme Powell Graham Kevin Greene Spencer Greene Stacey Hail Laurie Seidel Halmo Riley Hartmann Benjamin W. Hatten Kennon Heard

10.1007/s13181-022-00910-6 article EN Journal of Medical Toxicology 2022-09-07
Alexandra Amaducci Sharan Campleman Shao Li Dana L. Karshenas Meghan B. Spyres and 95 more Lynn A. Farrugia A. Min Kang Rachel Culbreth Paul M. Wax Jeffrey Brent Kim Aldy Jennifer Acciani Elizabeth Adeyeye Peter Akpunonu Timothy E. Albertson Adam Algren John Archer Sukhshant Atti Robert Avera Kavita Babu Alexander B. Baer Klara De Baerdemaeker Fatma Al Balushi Hassan Al Balushi Kevin Baumgartner Gillian A. Beauchamp Vik Bebarta Melisa Lai Becker Noah Berland David J. Betting Michael C. Beuhler Steven Bird Matthew Blundell Heather A. Borek Evan Bradley Nicklaus Brandehoff Marielle Brenner Daniel Brooks Jennie Buchanan Michele M. Burns Alfred Cahana Diane P. Calello Vincent Calleo Alexa Camarena-Michel Joshua Canning Dazhe Cao Jennifer Carey Joshua Carlson Joseph Carpenter Stephanie Carreiro Emma Cassidy Jorge Andrés Ramos Castañeda Rachel Castelli Trevor Cerbini Edward Certaruk Nathan Charlton Richard Chen James Chenoweth Samy Chettat Michael Christian Richard Church Joseph Clemons Daniel Colby Ryan K. Cole Grant Thomas Comstock Albert Conicella Matthew D. Cook Matthew S. Correia Robert A. Cox Steven D. Curry Arthur Daigh Paul I. Dargan John D DelBianco Jason M. Devgun Christopher Dion William H. Dribben Bernard Eisenga Lindsey Claire Epperson Rita Farah Henry C. Farrar Chris Feng Sing-Yi Feng Derek J Fikse Jonathan Ford Carolyn Fox K.A. French Blake Froberg Jakub Furmaga Melissa Gittinger David Goldberger Will Goodrich Kimberlie A. Graeme Powell Graham Kevin Greene Spencer Greene Howard A. Greller Matt Griswold Stacey Hail Thao-Phuong Christy Hallett Laurie Seidel Halmo

10.1007/s13181-023-00962-2 article EN Journal of Medical Toxicology 2023-08-29
Meghan B. Spyres Kim Aldy Lynn A. Farrugia A. Min Kang Jennifer S. Love and 95 more Sharan Campleman Shao Li Alexandra Amaducci Evan S. Schwarz Paul M. Wax Jeffery Brent Jennifer Acciani Peter Akpunonu Steven E. Aks D. Adam Algren Sukhshant Atti Robert Avera Richard A. Baum Gillian A. Beauchamp D. Bentur Michael C. Beuhler K. L. Boyle Michael Brenner Rebecca Bruccoleri Megan Burns B. Button Diane P. Calello John Canning Robert D. Cannon Dazhe Cao Jennifer Carey Joseph Carpenter Jorge Andrés Ramos Castañeda Riccardo Castelli Alice Cates Vincent Ceretto Robert HC Chen Michael Christian Kenneth R. Conner Maurice Cook Matthew S. Correia Paul I. Dargan Jonathan de Olano T. DeGelorm Jason M. Devgun William H. Dribben B E. Eisenga C. Neill Epperson Daria Falkowitz Henry C. Farrar Feng Sun D. Fernández Derek J Fikse A. Filip Y. Finkelstein Edwin B. Fisher Jonathan Ford Jakub Furmaga Mellisa Gittinger David Goldberger Rachel Gorodetsky Spencer Greene Matthew K. Griswold Sofia Hail Riley Hartmann Robert G. Hendrickson Michelle A. Hieger Michael Hodgman Christopher P. Holstege Christopher Hoyte Alejandro Hughes L. James Mohamed Jefri Bryan Judge Louise Kao Keren Katz Ziad Kazzi Emily Kiernan Hyung Min Kim R Kirschner Andrew L. Koons Janice M. Kowalski Shana Kusin Rebecca Latch Michael P. Levine Erica L. Liebelt David Liss Yu Liu C. Y. Lo D. E. Loughran Scott Lucyk Alison Lydecker Gregory Makar Alex F. Manini Michael B. Marlin J. McFalls Eric McGillis Neil B. McKeown Christopher Meaden K. Meadors

10.1007/s13181-021-00854-3 article EN Journal of Medical Toxicology 2021-09-17

Objective: To describe a large regional poison center's experience managing an outbreak of long-acting anticoagulant rodenticide (LAAR) poisoning associated with synthetic cannabinoid (SC) use.Methods: This is retrospective review exposures reported to the Illinois Poison Center between March 10 and August 1, 2018. All cases coded as exposure Δ9-tetrahydrocannabinol homologs were identified. Patients suspected SC use, positive LAAR testing, coagulopathy (signs or symptoms bleeding...

10.1080/15563650.2019.1690149 article EN Clinical Toxicology 2019-12-04

Introduction Patients with opioid use disorder may have difficulty transitioning from full-agonist opioids to sublingual buprenorphine due the risk of precipitated withdrawal. Novel strategies been developed facilitate this transition, including micro-dosing transdermal buprenorphine. We began using a transition strategy at our hospital in 2019.Methods performed retrospective observational cohort study patients treated (prescribed or recreational) while hospitalized between January 2019 and...

10.1080/15563650.2022.2028802 article EN Clinical Toxicology 2022-01-20
Coming Soon ...